BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 9803201)

  • 41. Oral contraceptives: therapeutic uses and quality-of-life benefits--case presentations.
    Sulak PJ
    Contraception; 1999 Jan; 59(1 Suppl):35S-38S. PubMed ID: 10342095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Oral contraception: disadvantages of estrogen reduction].
    Denis C
    Contracept Fertil Sex (Paris); 1993 Jun; 21(6):481-8. PubMed ID: 12318238
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
    Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
    Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ovarian cancer hormonal and environmental risk effect.
    Vo C; Carney ME
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):687-700, viii. PubMed ID: 18061864
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Estrogen dose in oral contraceptives: FDA committee examines safety and utility of 50 mcg estrogen OCs.
    Contracept Rep; 1994 Mar; 5(1):10-3. PubMed ID: 12287738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Health benefits of oral contraceptives.
    Jensen JT; Speroff L
    Obstet Gynecol Clin North Am; 2000 Dec; 27(4):705-21. PubMed ID: 11091985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Effect of combined hormonal oral contraceptives on several body systems].
    Simeonova L
    Akush Ginekol (Sofiia); 1976; 15(3):220-2. PubMed ID: 998936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The contraception needs of the perimenopausal woman.
    Hardman SM; Gebbie AE
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):903-15. PubMed ID: 24990143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Contraception and cancer prevention.
    Ursin G; Spicer DV; Pike MC
    Adv Contracept Deliv Syst; 1994; 10(3-4):369-86. PubMed ID: 12287845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Contraception for women over 40].
    Erny R; Mathet M
    Contracept Fertil Sex (Paris); 1984 Dec; 12(12):1323-34. PubMed ID: 12266611
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Longitudinal evaluation of perimenopausal bone loss: effects of different low dose oral contraceptive preparations on bone mineral density.
    Gambacciani M; Cappagli B; Lazzarini V; Ciaponi M; Fruzzetti F; Genazzani AR
    Maturitas; 2006 May; 54(2):176-80. PubMed ID: 16332417
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular risk of oral contraceptives. Low, and mainly in women at risk.
    Prescrire Int; 1998 Aug; 7(36):118-24. PubMed ID: 10342951
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study.
    Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G
    Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.
    Bray F; Dos Santos Silva I; Moller H; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1132-42. PubMed ID: 15894663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Choosing contraception for adolescents].
    Wemeau-jacquemont C
    NPN Med; 1985 Feb; 5(84):185-9. PubMed ID: 12280585
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The myth about contraceptives and breast cancer.
    Ibekwe J
    Dly Times; 1993 Mar; ():7. PubMed ID: 12179509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [How hazardous is the use of female steroid hormones?].
    Orbo A; Sager G
    Tidsskr Nor Laegeforen; 1997 Mar; 117(7):972-6. PubMed ID: 9103012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.